Association Analysis Between Albumin Level and Maxillofacial Space Infection Severity

Ying Huang1, Lei Lu2, Hetong Fei3

  • 1Attending, Maxillofacial Surgery Department, The Second Hospital of Lanzhou University, Lanzhou, China.

Abstract

Insights

Lower albumin (ALB) levels are linked to increased severity in maxillofacial space infections (MSI). Patients with ALB below 35 g/L face higher risks of prolonged hospital stays and complications, highlighting ALB as a crucial prognostic marker.

Area of Science:

  • Medical Science
  • Infectious Diseases
  • Surgical Pathology

Background:

  • Maxillofacial space infections (MSI) require timely intervention to prevent severe systemic complications.
  • Delayed treatment of MSI can lead to life-threatening conditions.

Purpose of the Study:

  • To investigate the association between serum albumin (ALB) levels and the severity of maxillofacial space infections (MSI).

Main Methods:

  • A retrospective cohort study analyzed 201 patients diagnosed with MSI between 2013 and 2023.
  • Albumin (ALB) levels were categorized (<30 g/L, 30-35 g/L, >35 g/L) and correlated with MSI severity indicators like length of stay (LOS) and mortality.
  • Statistical analyses included Chi-squared tests, ANOVA, t-tests, and multivariate logistic regression.

Main Results:

  • Lower ALB levels (<35 g/L) were significantly associated with an increased risk of prolonged LOS (P < .001).
  • Patients with ALB < 30 g/L had a 2.98 times higher risk of prolonged LOS compared to those with ALB > 35 g/L (P = .03).
  • Higher neutrophil proportion and white blood cell counts were observed in deceased patients, alongside a higher incidence of odontogenic infections.

Conclusions:

  • Serum albumin (ALB) levels below 35 g/L are identified as a significant risk factor for increased MSI severity and prolonged LOS.
  • Multiple space infections and descending necrotizing mediastinitis also correlate with increased MSI severity.
  • ALB levels serve as a potential prognostic marker for evaluating MSI severity and patient outcomes.